Market Place
Sourcing Support
All News #Library
Biotech
Watchmaker Licenses CRISPR-Cas9 IP from Caribou Bio
17 Feb 2026 //
PHARMIWEB
Caribou cuts 32% of staff, purges cell therapy pipeline
26 Apr 2025 //
FIERCE BIOTECH
Caribou cuts 32% of staff, further purges cell therapy pipeline
24 Apr 2025 //
FIERCE BIOTECH
CRISPR Ex Vivo Gene Editing Gets on Target With Caribou’s Hybrid
14 Oct 2024 //
BIOSPACE
Caribou Biosciences to Present Preclinical Data on CB-012
05 Mar 2024 //
PRESS RELEASE
Caribou Biosciences Announces Pricing of Upsized $125 Million Public Offering
13 Jul 2023 //
PRESS RELEASE
Caribou Biosciences Announces Proposed Public Offering of Common Stock
13 Jul 2023 //
PRESS RELEASE
Caribou Reports Positive Data from Phase 1 Trial in r/r B-NHL
13 Jul 2023 //
PRESS RELEASE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.